Supernus Pharmaceuticals, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Jul 31, 2025
  • No warning letters matched by name
Inspections 6 0 OAI
Recalls 3 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Supernus Pharmaceuticals, Inc. has 3 FDA recalls, 6 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Supernus Pharmaceuticals, Inc." is on file.

What these totals cover: FDA records filed under the name "Supernus Pharmaceuticals, Inc." and its spelling variant "Supernus Pharmaceuticals".

Latest recall
D-0833-2026 · Class III · Aug 31, 2026
Latest inspection
Jul 31, 2025 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls3Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections6Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Supernus Pharmaceuticals, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Supernus Pharmaceuticals, Inc.: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600020
202510000
202400000
202300000
202200000
202100000
202000000
201920000
201800000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Supernus Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Supernus Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

3 recall records from Jul 12, 2016 to Aug 31, 2026.

NumberClassProductDate
D-0833-2026Class IIITrokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by…Aug 31, 2026
D-0758-2026Class IIITrokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by…Jul 6, 2026
D-0112-2017Class IITrokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only…Jul 12, 2016

Recent FDA inspections

6 inspections from Jun 19, 2014 to Jul 31, 2025.

DateSiteProductClassificationFEI
Jul 31, 2025Rockville, MDDrugsNo Action Indicated (NAI)3005209462
Oct 10, 2019Rockville, MDDrugsNo Action Indicated (NAI)3005209462
Jul 10, 2019Rockville, MDDrugsNo Action Indicated (NAI)3005209462
Feb 3, 2017Rockville, MDDrugsVoluntary Action Indicated (VAI)3005209462
Feb 23, 2015Rockville, MDDrugsNo Action Indicated (NAI)3005209462
Jun 19, 2014Rockville, MDDrugsNo Action Indicated (NAI)3005209462
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3005209462Rockville, MD6Jul 31, 2025

Supernus Pharmaceuticals, Inc. and the FDA: common questions

Has Supernus Pharmaceuticals, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Supernus Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Supernus Pharmaceuticals, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Supernus Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Supernus Pharmaceuticals, Inc.?

The most recent FDA inspection on file ended Jul 31, 2025 at Rockville, MD and was classified NAI. FDA has 6 inspections of Supernus Pharmaceuticals, Inc. on file.

Has Supernus Pharmaceuticals, Inc. had an FDA recall?

Yes. Supernus Pharmaceuticals, Inc. has 3 FDA recalls on record. The most recent started Aug 31, 2026.

Need more than this page shows? Ask about Supernus Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.